PrintContact
 
  • Home
  • About Us
  • Sativex
  • R&D
  • Investors
  • Media
GW Pharmaceuticals
  • Press Releases
  • Media Contacts
  • Notes to Editors
  • Image Library
  • Home
  • Media

Media

Welcome to the media section of the GW website, dedicated to providing useful information for press enquiries.

This section contains current and previous press releases, notes to editors, image library and media contact information.

For a dedicated page relating to Sativex click here

 Press Releases

Press Release

Health Canada Grants Full Approval of Sativex For the Treatment of Spasticity Due to Multiple Sclerosis

Porton Down, UK; Toronto, Canada – August 31, 2010 – GW Pharmaceuticals plc (AIM: GWP) and Bayer Inc...

Press Release

Spanish Sativex Approval

• Spanish health authorities grant regulatory approval for Sativex®, the first new treatment for MS-...

Press Releases

Notes to Editors

  • GW in General
  • Cannabinoids & Cannabis-Based Medicines
  • Sativex
  • Investor Relations

FAQs

Image Library

Image Library

Image Library

media contacts
 
 

© GW Pharmaceuticals 2009

  • Home
  • Sitemap
  • Accessibility
  • Disclosure & Disclaimer
  • Contact
  • Email Alerts
 

Website designed and developed by www.emperordesign.co.uk